• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight

A regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis & other musculoskeletal disorders, oncology and dermatology diseases.
View the full Corporate Spotlight arrow Created with Sketch.

Regeneus achieves major milestones

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RGS
Regeneus closer to Japan deal after take up of rights issue shortfall
11/02/20 3 529
11/02/20 Last post  bioqld Comments Created with Sketch.  3  Views Created with Sketch.  529 
RGS 07/02/20 16 2.2K
07/02/20 Last post  monoply Comments Created with Sketch.  16  Views Created with Sketch.  2.2K 
RGS 06/02/20 0 125
06/02/20 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  125 
RGS 06/02/20 0 136
06/02/20 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  136 
RGS 24/01/20 21 4.6K
24/01/20 Last post  monoply Comments Created with Sketch.  21  Views Created with Sketch.  4.6K 
RGS 20/01/20 1 259
20/01/20 Last post  emmakate0511 Comments Created with Sketch.  1  Views Created with Sketch.  259 
RGS
News: RGS Regeneus Ltd Mutually Agreed With AGC Inc To Terminate Manufacturing Licence And JV...
20/12/19 0 109
20/12/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  109 
RGS 20/12/19 0 144
20/12/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  144 
RGS 18/12/19 1 309
18/12/19 Last post  TDA Comments Created with Sketch.  1  Views Created with Sketch.  309 
RGS
News: RGS Regeneus Receives $50K In Funding As Part Of Innovation Connections Grant
18/12/19 0 75
18/12/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  75 
RGS 04/12/19 18 4.2K
04/12/19 Last post  TDA Comments Created with Sketch.  18  Views Created with Sketch.  4.2K 
RGS 21/11/19 0 207
21/11/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  207 
RGS 21/11/19 0 226
21/11/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  226 
RGS 21/11/19 0 185
21/11/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  185 
RGS 20/11/19 0 116
20/11/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  116 
RGS 20/11/19 0 126
20/11/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  126 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Appendix 3Ys
06 Feb 17:07
 
Appendix 3G
06 Feb 16:49
 
Appendix 4C - Quarterly
31 Jan 09:48
 
Appendix 3G
20 Jan 10:33
 
Proposed issue of Securities - RGS
20 Dec 10:46
 
AGC Agreement termination paves way for commercial partner
20 Dec 10:33
 
View More arrow Created with Sketch.
(20min delay)
Last
6.3¢
Change
0.001(1.61%)
Mkt cap ! $17.50M
Open High Low Value Volume
6.5¢ 6.5¢ 6.3¢ $1.431K 22.37K

Buyers (Bids)

No. Vol. Price($)
1 89041 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 125000 2
View Market Depth
Last trade - 13.01pm 14/02/2020 (20 minute delay) ?
(live)
Last
6.3¢
  Change
0.001 ( 3.28 %)
Open High Low Volume
6.3¢ 6.3¢ 6.3¢ 8259
Last updated 12.14pm 14/02/2020 (live) ?
RGS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.